Cargando…
Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy
Immunotherapy has emerged as a promising strategy for cancer treatment, in which durable immune responses were generated in patients with malignant tumors. In the past decade, biomaterials have played vital roles as smart drug delivery systems for cancer immunotherapy to achieve both enhanced therap...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334721/ https://www.ncbi.nlm.nih.gov/pubmed/34368109 http://dx.doi.org/10.3389/fbioe.2021.723490 |
_version_ | 1783733071168667648 |
---|---|
author | Cui, Rongwei Wu, Qiang Wang, Jing Zheng, Xiaoming Ou, Rongying Xu, Yunsheng Qu, Shuxin Li, Danyang |
author_facet | Cui, Rongwei Wu, Qiang Wang, Jing Zheng, Xiaoming Ou, Rongying Xu, Yunsheng Qu, Shuxin Li, Danyang |
author_sort | Cui, Rongwei |
collection | PubMed |
description | Immunotherapy has emerged as a promising strategy for cancer treatment, in which durable immune responses were generated in patients with malignant tumors. In the past decade, biomaterials have played vital roles as smart drug delivery systems for cancer immunotherapy to achieve both enhanced therapeutic benefits and reduced side effects. Hydrogels as one of the most biocompatible and versatile biomaterials have been widely applied in localized drug delivery systems due to their unique properties, such as loadable, implantable, injectable, degradable and stimulus responsible. Herein, we have briefly summarized the recent advances on hydrogel-by-design delivery systems including the design of hydrogels and their applications for delivering of immunomodulatory molecules (e.g., cytokine, adjuvant, checkpoint inhibitor, antigen), immune cells and environmental regulatory substances in cancer immunotherapy. We have also discussed the challenges and future perspectives of hydrogels in the development of cancer immunotherapy for precision medicine at the end. |
format | Online Article Text |
id | pubmed-8334721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83347212021-08-05 Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy Cui, Rongwei Wu, Qiang Wang, Jing Zheng, Xiaoming Ou, Rongying Xu, Yunsheng Qu, Shuxin Li, Danyang Front Bioeng Biotechnol Bioengineering and Biotechnology Immunotherapy has emerged as a promising strategy for cancer treatment, in which durable immune responses were generated in patients with malignant tumors. In the past decade, biomaterials have played vital roles as smart drug delivery systems for cancer immunotherapy to achieve both enhanced therapeutic benefits and reduced side effects. Hydrogels as one of the most biocompatible and versatile biomaterials have been widely applied in localized drug delivery systems due to their unique properties, such as loadable, implantable, injectable, degradable and stimulus responsible. Herein, we have briefly summarized the recent advances on hydrogel-by-design delivery systems including the design of hydrogels and their applications for delivering of immunomodulatory molecules (e.g., cytokine, adjuvant, checkpoint inhibitor, antigen), immune cells and environmental regulatory substances in cancer immunotherapy. We have also discussed the challenges and future perspectives of hydrogels in the development of cancer immunotherapy for precision medicine at the end. Frontiers Media S.A. 2021-07-21 /pmc/articles/PMC8334721/ /pubmed/34368109 http://dx.doi.org/10.3389/fbioe.2021.723490 Text en Copyright © 2021 Cui, Wu, Wang, Zheng, Ou, Xu, Qu and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Cui, Rongwei Wu, Qiang Wang, Jing Zheng, Xiaoming Ou, Rongying Xu, Yunsheng Qu, Shuxin Li, Danyang Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy |
title | Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy |
title_full | Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy |
title_fullStr | Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy |
title_full_unstemmed | Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy |
title_short | Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy |
title_sort | hydrogel-by-design: smart delivery system for cancer immunotherapy |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334721/ https://www.ncbi.nlm.nih.gov/pubmed/34368109 http://dx.doi.org/10.3389/fbioe.2021.723490 |
work_keys_str_mv | AT cuirongwei hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy AT wuqiang hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy AT wangjing hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy AT zhengxiaoming hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy AT ourongying hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy AT xuyunsheng hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy AT qushuxin hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy AT lidanyang hydrogelbydesignsmartdeliverysystemforcancerimmunotherapy |